The COVID-19 pandemic has deeply and globally impacted usual procedures and patientsmanagement in cancer centers. The aim of this study is to set-up and collect indicatorsto follow-up the activities of different cancer pathologies before and during thepandemic. Patients loss' of chance will be analysed in term of diagnosis and access tocare (surgery, antineoplastic treatments).Data collection will focus on the analysis of 2 specific pathologies for French patientsin the "Auvergne-Rhône Alpes" Area: peritoneal carcinosis and hepatocellular carcinoma.
Not Provided
Other: COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.
The following items will be collected
- Diagnostic date
- Diagnostic stage
- Date of surgery
- Date of surgery appointment
- First antineoplastic treatment date
- Last antineoplastic treatment date
- Number of treatment cycles recommanded by MDTM
Inclusion Criteria:
- Patients hospitalized in France for peritoneal carcinosis or hepatocellular
carcinoma between 2017 and 2020.
Exclusion Criteria:
- Patients who did not allow the reuse of their medical data for research
Hopital Lyon sud, Hospices civils de Lyon
Pierre-Bénite, France
Investigator: Julien PERON, MD
Contact: 4 78 86 37 75
julien.peron@chu-lyon.fr
Not Provided